What We're Reading: Page
Industry reads hand-picked by our editors
Jan 28, 2021
-
The Washington Post
Millions earmarked for public health emergencies were used to pay for unrelated projects, inspector general says
-
Evaluate Vantage
Vir becomes a biotech bubble poster child
-
The New York Times
A Scientist Is Arrested, and Academics Push Back
-
Reuters
Telehealth company Ro explores deal to go public: sources
Jan 27, 2021
-
Bloomberg
Pfizer to Deliver U.S. Covid Vaccine Doses Faster Than Expected
-
The Boston Globe
The pandemic hasn't slowed hiring at local biotech and tech companies
-
Regulatory Focus
Inspections down in 2020, but CDER hit most goal dates
-
STAT
FTC sues drug makers over allegedly illegal deal over an opioid painkiller
Jan 26, 2021
-
STAT
'But I never smoked': A growing share of lung cancer is turning up in never-smokers
-
Science
Proud of vaccine success, Warp Speed's ex–science head talks politics, presidents, and future pandemics
-
Reuters
Novartis's regulatory delays add to pandemic sales hit
-
Kaiser Health News
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster
Jan 25, 2021
-
C&EN
COVID-19: Science's greatest test
-
STAT
Colchicine, a gout drug, shows preliminary promise for Covid-19
-
Kaiser Health News
They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma
-
The Wall Street Journal
Biden Team Promises New Look in Trade Policy
Jan 22, 2021
-
The Washington Post
Vaccine shortages intensify while some doses sit on shelves, an obstacle to national strategy promised by Biden
-
MedPage Today
New Safety Concern for Migraine Drug?
-
Bloomberg
J&J Vaccine Trial Has Enough Data to Analyze Soon, Fauci Says
-
Future Human
‘Deleted’ DNA Data Just Reappeared on a Popular Database
Jan 21, 2021
-
Reuters
California resumes Moderna COVID-19 vaccine usage after pause
-
STAT
CEO of Mark Cuban's generics company talks drug pricing, manufacturing
-
Associated Press
Fire hits building at Indian producer of COVID-19 vaccines
-
Endpoints News
BIO looks to restructure, laying off staff amid challenge to the trade org’s normal face-to-face style
Jan 20, 2021
-
The Wall Street Journal
Janet Woodcock to Lead FDA on Interim Basis
-
The Washington Post
Elderly begin to drop out of Novavax vaccine trial to get Pfizer and Moderna shots
-
Evaluate Vantage
The pandemic releases its grip on clinical trials
-
Vanity Fair
How Trump's COVID Chaos Drowned the FDA in Junk Science
Previous
